Optimizing care with teamsThere’s a patchwork of provincial supports for team-based care, but do they boost efficiency? PPIs—An easy ‘hi’ but a difficult goodbyeIt is important to inform patients that they are quite likely to experience some rebound symptoms when reducing the dose or discontinuing their PPIs. Reimagining inbox management Some doctors are using sophisticated techniques to triage faxes and AI is taking inbox management up a notch. Beyond the numbers: The heart of pharmacy Our first responsibility is to our patients, to ensure that they get the best care, free from arbitrary targets. Seven new drug indications physicians and pharmacists should know about Get the info you need on these new drug indications, part of our drug news roundup for May. Editorial: New ideas from surprising sources Along with April showers and the promise of warm sunshiny days to come, Spring is traditionally pharmacy conference season. GLP-1 and dual GIP/GLP-1 receptor agonists An update on benefits, risks and emerging indications. Three new generics physicians and pharmacists should know about Get the info you need on these new generics, part of our drug news roundup for May. NEW PRODUCT: Winrevair Get the info you need on this new product, part of our drug news roundup for May. NEW PRODUCT: Remdantry Get the info you need on this new product, part of our drug news roundup for May. First Previous 3 4 5 6 7 Next Last
